In the highly specialized world of chemical manufacturing and pharmaceutical R&D, the ability to reliably source critical raw materials is fundamental to project success. Methyl 2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolinecarboxylate, identified by its CAS number 121659-86-7, is a sophisticated organic compound that serves as a vital intermediate in various synthetic processes, most notably in the pharmaceutical industry for the production of Pitavastatin. This article will guide you through the considerations for sourcing this essential compound.

Methyl 2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolinecarboxylate is an organic molecule with a molecular formula of C20H16FNO2 and a molecular weight of approximately 321.34. It is typically supplied as a white solid, signifying a level of purity critical for its use in downstream applications, particularly in pharmaceutical synthesis. Its structure, which includes a quinoline core, a cyclopropyl group, and a fluorophenyl substituent, makes it a valuable 'pharmaceutical intermediate'. The incorporation of fluorine atoms, as seen in the fluorophenyl moiety, can often enhance the lipophilicity and metabolic stability of drug molecules, improving their efficacy and duration of action.

The primary utility of this compound is its role in the 'pitavastatin intermediate synthesis'. Pitavastatin is a statin drug used to manage cholesterol levels and reduce the risk of cardiovascular disease. The multi-step synthesis of this API requires high-purity intermediates to ensure the quality and safety of the final product. Therefore, a consistent and dependable supply of Methyl 2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolinecarboxylate is essential. This leads many companies to actively 'buy methyl 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylate' from specialized chemical providers.

The selection of 'methyl 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylate suppliers' is a crucial step in the procurement process. Factors such as product purity, consistency across batches, lead times, and compliance with regulatory standards are paramount. Companies like NINGBO INNO PHARMCHEM CO.,LTD. are recognized for their dedication to quality assurance and their ability to meet the stringent demands of the pharmaceutical sector. When sourcing, it is advisable to review supplier certifications, batch analysis data, and customer testimonials to ensure reliability.

The compound's classification as a 'carboxylic acid methyl ester intermediate' and its 'fluorophenyl compound' nature further underscore its utility in complex organic synthesis. Researchers engaged in 'drug research' often rely on such specialized building blocks to explore new therapeutic avenues. The availability of this compound facilitates innovation in developing advanced pharmaceutical formulations and novel drug candidates. Therefore, understanding the 'advanced pharmaceutical building blocks' market is key for any organization involved in cutting-edge chemical development.

In conclusion, Methyl 2-Cyclopropyl-4-(4-Fluorophenyl)-3-Quinolinecarboxylate (CAS 121659-86-7) is a critical component for pharmaceutical manufacturing and research. By understanding its properties and the importance of reliable sourcing from qualified 'methyl 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinecarboxylate suppliers', companies can ensure the efficiency and integrity of their projects, ultimately contributing to the development of essential medicines.